AEPGX
Price
$65.36
Change
+$0.75 (+1.16%)
Updated
Aug 21 closing price
Net Assets
137.41B
RIVAX
Price
$22.12
Change
+$0.17 (+0.77%)
Updated
Aug 21 closing price
Net Assets
2.69B
Interact to see
Advertisement

AEPGX vs RIVAX

AEPGX vs RIVAX Comparison Chart in %
View a ticker or compare two or three
VS
AEPGX vs. RIVAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a StrongBuy and RIVAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 137B vs. RIVAX (2.69B). AEPGX pays higher dividends than RIVAX: AEPGX (2.56) vs RIVAX (0.87). AEPGX was incepted earlier than RIVAX: AEPGX (42 years) vs RIVAX (7 years). RIVAX (1.61) is less costly to investors than AEPGX (0.83). AEPGX is a more actively managed with annual turnover of: 50.00 vs. RIVAX (32.00). AEPGX (250) and RIVAX (250) have matching initial minimum investment requirements. RIVAX annual gain was more profitable for investors over the last year : 13.63 vs. AEPGX (8.66). RIVAX return over 5 years is better than : 29.23 vs. AEPGX (1.00).
AEPGXRIVAXAEPGX / RIVAX
Total Expense Ratio0.831.6052%
Annual Report Gross Expense Ratio0.831.6152%
Fund Existence42 years7 years-
Gain YTD8.01510.05080%
Front Load6%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets137B2.69B5,089%
Annual Yield % from dividends2.560.87295%
Returns for 1 year8.6613.6364%
Returns for 3 years30.3046.4365%
Returns for 5 years1.0029.233%
Returns for 10 years47.95N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDEYX22.040.15
+0.69%
Columbia Intrinsic Value Institutional 3
ADCIX24.720.16
+0.65%
American Century Disciplined Growth I
MFEHX180.291.02
+0.57%
MFS Growth R3
TRSLX6.590.03
+0.46%
Transamerica Small Cap Value R
DSEFX42.310.18
+0.43%
Domini Impact Equity Investor